drugset / Trial / NCT07245667

Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study

NCT07245667

Phase 2 Recruiting 150 enrolled Propedix, Inc.
Non-randomizedSequentialOpen-labelTreatment

Summary

This study is designed to evaluate the safety and effectiveness of multiple 1% tolnaftate formulations delivered through novel stick-based vehicles in individuals with tinea pedis (athlete's foot).

Timeline

Start
2024-12-30
Primary completion
2026-02
Completion
2026-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Tolnaftate Small molecule 1 % Topical

Indications